| Financial Year |
March 31 2023 |
| Monetary Funds |
301,528,753.72 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
154,444,685.47 |
| Accounts Receivable |
490,014,154.47 |
| Advances to Suppliers |
29,230,634.46 |
| Other Receivables |
47,579,339.32 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
405,687,384.49 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
16,177,857.02 |
| Total Current Assets |
1,598,856,604.38 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
135,891,453.23 |
| Investment Properties |
2,560,520.33 |
| Fixed Assetes |
780,895,957.93 |
| Under-construction Projects |
98,184,799.05 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
67,571,864.65 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
265,523.83 |
| Deferred Income Tax Assets |
21,779,342.28 |
| Other Non-Current Assets |
103,733,070.44 |
| Sub-Total of Non-Current Assets |
1,221,238,270.40 |
| Total Assets |
2,820,094,874.78 |
| Short-Term Loans |
274,897,738.21 |
| Trading Financial liabilities |
-- |
| Notes Payable |
64,065,766.15 |
| Accounts Payable |
306,113,146.98 |
| Accounts Received In Advance |
141,683.00 |
| Employee Compensation Payable |
12,201,974.24 |
| Taxes Payable |
4,038,272.12 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
28,720,878.26 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
115,739,881.27 |
| Other Current Liabilities |
59,894,193.71 |
| Sub-Total of Current Liabilities |
872,454,557.03 |
| Long-term Loans |
261,501,879.60 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
15,363,299.93 |
| Deferred Income Tax Liabilities |
9,230,862.50 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
330,216,637.46 |
| Total Liabilities |
1,202,671,194.49 |
| Paid-In Capital(Or Share Stock) |
208,792,798.00 |
| Capital Surplus |
442,519,637.05 |
| Surplus Reserve |
99,289,835.61 |
| LESS:Treasury Stock |
17,222,544.00 |
| Undistributed Profits |
862,498,814.13 |
| Minority Stockholder's Interest |
21,545,139.50 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,595,878,540.79 |
| Owner's Equity（Stockholder's Equity） |
1,617,423,680.29 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,820,094,874.78 |
